133 related articles for article (PubMed ID: 6814596)
1. Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen.
Berche C; Mach JP; Lumbroso JD; Langlais C; Aubry F; Buchegger F; Carrel S; Rougier P; Parmentier C; Tubiana M
Br Med J (Clin Res Ed); 1982 Nov; 285(6353):1447-51. PubMed ID: 6814596
[TBL] [Abstract][Full Text] [Related]
2. [Use of tomographic scintigraphy with radio-labelled monoclonal antibodies for detecting human digestive cancers and medullary cancers of the thyroid].
Lumbroso J; Berche C; Mach JP; Rougier P; Aubry F; Buchegger F; Lasser P; Parmentier C; Tubiana M
Bull Cancer; 1983; 70(2):96-102. PubMed ID: 6871490
[TBL] [Abstract][Full Text] [Related]
3. Localisation of gastrointestinal cancer with a 131 I labelled monoclonal antibody to CEA.
Allum WH; MacDonald F; Anderson P; Fielding JW
Br J Cancer; 1986 Feb; 53(2):203-10. PubMed ID: 3954942
[TBL] [Abstract][Full Text] [Related]
4. [Immunoscintigraphy with emission tomography in cancers of the thyroid].
Parmentier C; Lumbroso J; Schlumberger M; Gardet P; Mach JP; Berche C; Rougier P; Caillou B; Tubiana M
Ann Med Interne (Paris); 1984; 135(5):345-50. PubMed ID: 6333200
[TBL] [Abstract][Full Text] [Related]
5. [Radioimmunoscintigraphy using SPECT: methodology, problems and clinical experiences].
Bares R; Fass J; Truong S; Büll U; Schumpelick V
Nuklearmedizin; 1987 Oct; 26(5):202-5. PubMed ID: 3501573
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.
Zanin DE; van Dongen A; Hoefnagel CA; Bruning PF
J Nucl Med; 1990 Nov; 31(11):1854-5. PubMed ID: 2231001
[TBL] [Abstract][Full Text] [Related]
7. Localisation of tumour deposits by external scanning after injection of radiolabelled anti-carcinoembryonic antigen.
Dykes PW; Hine KR; Bradwell AR; Blackburn JC; Reeder TA; Drolc Z; Booth SN
Br Med J; 1980 Jan; 280(6209):220-2. PubMed ID: 7427084
[TBL] [Abstract][Full Text] [Related]
8. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen.
Juweid M; Sharkey RM; Behr T; Swayne LC; Rubin AD; Herskovic T; Hanley D; Markowitz A; Dunn R; Siegel J; Kamal T; Goldenberg DM
J Clin Oncol; 1996 Apr; 14(4):1209-17. PubMed ID: 8648376
[TBL] [Abstract][Full Text] [Related]
9. Role of 131I-labelled anti-CEA/CA 19-9 monoclonal antibodies in the diagnosis and follow-up of gastrointestinal tumors.
Giordano A; Rufini V; Campioni P; Vaccaro A; Troncone L
Int J Rad Appl Instrum B; 1989; 16(2):151. PubMed ID: 2715009
[No Abstract] [Full Text] [Related]
10. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.
Reiners C; Eilles C; Spiegel W; Becker W; Börner W
Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964
[TBL] [Abstract][Full Text] [Related]
11. Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma.
Rufini V; Castaldi P; Treglia G; Perotti G; Gross MD; Al-Nahhas A; Rubello D
Biomed Pharmacother; 2008 Mar; 62(3):139-46. PubMed ID: 17892924
[TBL] [Abstract][Full Text] [Related]
12. Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
Vuillez JP; Peltier P; Caravel JP; Chetanneau A; Saccavini JC; Chatal JF
J Clin Endocrinol Metab; 1992 Jan; 74(1):157-63. PubMed ID: 1727816
[TBL] [Abstract][Full Text] [Related]
13. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
[TBL] [Abstract][Full Text] [Related]
14. Iodine-131 labeled anti-CEA antibodies uptake by Hürthle cell carcinoma.
Abdel-Nabi H; Hinkle GH; Falko JM; Kelly D; Olsen JO; Martin EW
Clin Nucl Med; 1985 Oct; 10(10):713-5. PubMed ID: 4075656
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies.
Juweid M; Sharkey RM; Behr T; Swayne LC; Herskovic T; Pereira M; Rubin AD; Hanley D; Dunn R; Siegel J; Goldenberg DM
J Nucl Med; 1996 Jun; 37(6):905-11. PubMed ID: 8683309
[TBL] [Abstract][Full Text] [Related]
16. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten.
Hosono M; Hosono MN; Kraeber-Bodéré F; Devys A; Thédrez P; Fiche M; Gautherot E; Barbet J; Chatal JF
J Nucl Med; 1998 Sep; 39(9):1608-13. PubMed ID: 9744353
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunodetection of gastrointestinal neoplasms with antibodies to carcinoembryonic antigen.
Hine KR; Bradwell AR; Reeder TA; Drolc Z; Dykes PW
Cancer Res; 1980 Aug; 40(8 Pt 2):2993-6. PubMed ID: 7397694
[TBL] [Abstract][Full Text] [Related]
19. Targeting and initial radioimmunotherapy of medullary thyroid carcinoma with 131I-labeled monoclonal antibodies to carcinoembryonic antigen.
Juweid M; Sharkey RM; Behr T; Swayne LC; Rubin AD; Hanley D; Herskovic T; Markowitz A; Siegel J; Goldenberg DM
Cancer Res; 1995 Dec; 55(23 Suppl):5946s-5951s. PubMed ID: 7493375
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.
Oudoux A; Salaun PY; Bournaud C; Campion L; Ansquer C; Rousseau C; Bardet S; Borson-Chazot F; Vuillez JP; Murat A; Mirallié E; Barbet J; Goldenberg DM; Chatal JF; Kraeber-Bodéré F
J Clin Endocrinol Metab; 2007 Dec; 92(12):4590-7. PubMed ID: 17878252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
